Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÖzkan, Gülsüm
dc.contributor.authorUlusoy, Şükrü
dc.contributor.authorGeyik, Elif
dc.contributor.authorErdem, Yunus
dc.date.accessioned2022-05-11T14:39:57Z
dc.date.available2022-05-11T14:39:57Z
dc.date.issued2019
dc.identifier.issn1524-6175
dc.identifier.issn1751-7176
dc.identifier.urihttps://doi.org/10.1111/jch.13704
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8809
dc.description.abstractComplex mechanisms including genetic factors have been proposed in the pathogenesis of primary hypertension (HT). Micro RNAs (miRNAs) are single-stranded RNA molecules that are not converted into protein products. However, it has been established that genes regulate conversion into protein products. The primary aim of this study was to investigate the roles of miRNA 4516, miRNA 145, miRNA 24, and miRNA 181a in the pathogenesis of HT. The secondary aim was to investigate the relation between these miRNAs and renin, aldosterone, norepinephrine, renalase, and NOS. Fifty-two hypertensive and 51 control normotensive individuals under observation in the Cappadocia cohort were included in the study. miRNA 4516, miRNA 181a, miRNA 24, and miRNA 145 levels were measured using the ddPCR method. miRNA 4516 and norepinephrine levels were significantly higher in the HT group (P < .005 for both), while miRNA 145 levels were significantly lower (<.05). miRNA 4516 up-regulation (P < .05) and miRNA 145 down-regulation (P < .05) were identified as independent predictors of HT. Renalase exhibited negative correlation with miRNA 4516 and positive correlation with miRNA 145 in the patient and control group. In addition, negative correlation was present between miRNA 24 and NE and NOS and between miRNA 181a and NOS in the patient group. Our study identified, for the first time in the literature, miRNA 4516 up-regulation and miRNA 145 down-regulation as independent determinants of HT. Further studies performed in the light of our findings may lead to a better understanding of the pathogenesis and new therapeutic possibilities.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.identifier.doi10.1111/jch.13704
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjecthypertensionen_US
dc.subjectmiRNA 145en_US
dc.subjectmiRNA 181aen_US
dc.subjectmiRNA 24en_US
dc.subjectmiRNA 4516en_US
dc.subjectBlood-Pressureen_US
dc.subjectOverexpressionen_US
dc.subjectQuantificationen_US
dc.subjectMicrornasen_US
dc.subjectMir-181aen_US
dc.subjectReninen_US
dc.titleDown-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertensionen_US
dc.typearticleen_US
dc.relation.ispartofJournal of Clinical Hypertensionen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-5389-3143
dc.authorid0000-0003-0552-3911
dc.identifier.volume21en_US
dc.identifier.issue11en_US
dc.identifier.startpage1724en_US
dc.identifier.endpage1731en_US
dc.institutionauthorÖzkan, Gülsüm
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid8570900600
dc.authorscopusid6603926071
dc.authorscopusid16039387600
dc.authorscopusid56216377800
dc.authorwosidUlusoy, Sukru/AAL-9150-2021
dc.identifier.wosWOS:000495802800020en_US
dc.identifier.scopus2-s2.0-85073964773en_US
dc.identifier.pmid31556476en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster